Research Article

Prognostic Value of Combination of Controlling Nutritional Status and Tumor Marker in Patients with Radical Non-Small-Cell Lung Cancer

Table 2

Chi-square analysis of T-CONUT and patient characteristics.

Clinicopathological featuresGroup 1 (125)Group 2 (71)Group 3 (205)Group 4 (82)

Sex0.001
 Male56 (44.8)41 (57.7)126 (61.5)58 (70.7)
 Female69 (55.2)30 (42.3)79 (38.5)24 (29.3)
Age (years)0.209
 ≤6078 (62.4)47 (66.2)110 (53.7)49 (59.8)
 >6047 (37.6)24 (33.8)95 (46.3)33 (40.2)
BMI (kg/m2)0.093
 ≤23.3958 (46.4)34 (47.9)96 (46.8)51 (62.2)
 >23.3967 (53.6)37 (52.1)109 (53.2)31 (37.8)
SCC (ng/ml)<0.001
 ≤1.5120 (96.0)65 (91.5)166 (81.0)58 (70.7)
 >1.55 (4.0)6 (8.5)39 (19.0)24 (29.3)
CEA (ng/ml)0.275
 ≤586 (68.8)49 (69.0)144 (70.2)48 (58.5)
 >539 (31.2)22 (31.0)61 (29.8)34 (41.5)
NSE (ng/ml)<0.001
 ≤15.2111 (88.8)67 (94.4)137 (66.8)54 (65.9)
 >15.214 (11.2)4 (5.6)68 (33.2)28 (34.1)
Smoking history0.003
 No73 (58.4)39 (54.9)80 (39.0)35 (42.7)
 Yes52 (41.6)32 (45.1)125 (61.0)47 (57.3)
Tumor location0.302
 Left lung51 (40.8)29 (40.8)73 (35.6)39 (47.6)
 Right lung74 (59.2)42 (59.2)132 (64.4)43 (52.4)
Histological type<0.001
 Squamous cell carcinoma17 (13.6)21 (29.6)88 (42.9)31 (37.8)
 Adenocarcinoma105 (84.0)46 (64.8)108 (52.7)42 (51.2)
 Others3 (2.4)4 (5.6)9 (4.4)9 (11.0)
pTNM<0.001
 I84 (67.2)48 (67.6)110 (53.7)27 (32.9)
 II17 (13.6)12 (16.9)32 (15.6)20 (24.4)
 III24 (19.2)11 (15.5)63 (30.7)35 (42.7)